CalciMedica, Inc. (CALC)
1.15
0.00 (0.00%)
USD |
NASDAQ |
Oct 22, 16:00
1.22
+0.07
(+6.09%)
After-Hours: 20:00
CalciMedica Net Income (Quarterly) : -7.652M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.652M |
| March 31, 2026 | 4.976M |
| December 31, 2025 | -10.76M |
| September 30, 2025 | -7.804M |
| June 30, 2025 | -5.956M |
| March 31, 2025 | -5.042M |
| December 31, 2024 | -4.258M |
| September 30, 2024 | -5.618M |
| June 30, 2024 | -3.954M |
| March 31, 2024 | 0.13M |
| December 31, 2023 | -4.146M |
| September 30, 2023 | -4.619M |
| June 30, 2023 | -6.304M |
| March 31, 2023 | -19.29M |
| Date | Value |
|---|---|
| December 31, 2022 | 0.099M |
| September 30, 2022 | -2.581M |
| June 30, 2022 | -3.03M |
| March 31, 2022 | -3.63M |
| December 31, 2021 | -8.675M |
| September 30, 2021 | -7.989M |
| June 30, 2021 | -7.708M |
| March 31, 2021 | -11.45M |
| December 31, 2020 | -9.152M |
| September 30, 2020 | -4.716M |
| June 30, 2020 | -5.869M |
| March 31, 2020 | -7.794M |
| December 31, 2019 | -10.27M |
| September 30, 2019 | -10.20M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 210.00M |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 7.652M |
| EPS Diluted (Quarterly) | -2.237 |
| Enterprise Value | -2.348M |
| Earnings Yield | -590.2% |
| Normalized Earnings Yield | -564.78 |